Blog - Page 2527 of 5619

ThursdayJan 21, 2016 5:27 pm

Cancer Genetics (CGIX) at the Forefront of Personalized Medicine

Cancer Genetics, Inc. (NASDAQ: CGIX) is focused on the development of personalized genetic testing for the detection of various cancers, with the goal of significantly increasing treatment efficacy while reducing healthcare costs. CGI’s scientific advisory board includes leaders in the areas of hematological malignancies, solid tumor cancers, pharmacogenomics, and clinical trials administration. The company’s growing patent base consists of molecular-focused patents for the diagnosis, prognosis, and risk stratification of difficult-to-treat cancers, based on what the company calls “unique algorithms that take into account multiple chromosomal regions associated with particular disease outcomes or treatment decision”. CGI is heavily involved in the…

ThursdayJan 21, 2016 5:11 pm

The Clorox Company (CLX): A True Global Conglomerate with Community Values

The Clorox Company (NYSE: CLX) manufactures and markets consumer and professional products worldwide. The company operates through four segments: Cleaning, Household, Lifestyle, and International. Clorox is a global company with leading brands that have become household names, including its namesake bleach and cleaning products; Green Works naturally derived cleaning products; Ayudín and Poett home care products; Pine-Sol dilutable cleaner; Fresh Step cat litter; Kingsford charcoal; Hidden Valley and K.C. Masterpiece dressings and sauces; Brita water filtration products; Glad bags, wraps and containers; and Burt's Bees natural personal care products. Clorox manufactures products in more than two-dozen countries and markets them…

ThursdayJan 21, 2016 4:57 pm

Nike, Inc. (NKE) Continues Worldwide Growth

Nike, Inc. (NYSE: NKE), headquartered in Beaverton, OR, is the world’s leading sportswear and sporting goods company, with a market cap approaching $100 billion. Founded in 1964 as Blue Ribbon Sports, and changing its name to NIKE in 1971, the company offers a full range of sports related clothing, accessories, and equipment through sports and department stores and shops worldwide, as well as directly to consumers over the Internet. Nike’s stated mission is "To bring inspiration and innovation to every athlete in the world", adding that “if you have a body, you are an athlete”, the latter being a mantra…

ThursdayJan 21, 2016 3:34 pm

Alternet Systems, Inc. (ALYI) Featured in Wall Street Corner Special Report

Alternet Systems, Inc. (OTCQB: ALYI) was recently identified as a “promising, undervalued emerging technology leader” in a report by Wall Street Corner. As a result, Wall Street Corner Special Report, which is hailed as the premier discovery site for promising, yet undiscovered small- and micro-cap stocks featuring opportunities in an ethical, professional and responsible manner, has engaged Caprock Research to initiate ongoing research coverage on the company. An initial report is expected to be released by the end of this month. To view the initial release, visit http://www.wallstreetcornerreport.com/alyi-report The report went on to praise Alternet’s history of successfully developing digital…

ThursdayJan 21, 2016 2:53 pm

Stellar Biotechnologies, Inc. (SBOT) Announces Joint Venture With Neovacs S.A.

Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a California-based biotechnology company and world leader in the sustainable manufacture of keyhole limpet hemocyanin (KLH), a protein used for stimulating and measuring immune response, has announced plans to form a joint venture with Neovacs S.A., a French biotechnology company focused on an active immunotherapy technology platform. The joint venture will be for the manufacture of conjugated therapeutic vaccines based upon Stellar’s proprietary KLH protein, specifically to produce Neovacs' Kinoid product candidates, including IFNa-Kinoid, and to potentially produce other KLH-based immunotherapies on behalf of third party customers. However, negotiations are not complete and will continue…

ThursdayJan 21, 2016 2:31 pm

View Systems, Inc. (VSYM) Enters into Definitive Agreement to Acquire Y.M. Advantage, Inc.

Earlier today, View Systems, Inc. (OTC: VSYM), a manufacturer and installer of non-invasive weapons detection systems for government and commercial use, announced it has entered into a definitive agreement to acquire Y.M. Advantage, Inc. (YMA), a private corporation engaged in the acquisition, development and management of medical clinics providing treatment for various medical issues. Through this acquisition, View Systems aims to achieve greater market penetration while promoting sustainable financial growth. “As previously announced, our exploration and execution of M&A agreements are by no means an exit from our current focus of operations,” Gunther Than, chief executive officer of View Systems,…

ThursdayJan 21, 2016 1:02 pm

Nutra Pharma Corp. (NPHC) Offers a Suite of Pain Management Remedies

When someone is in pain, they cannot concentrate on anything other than how to alleviate that pain as quickly as possible, and many times, Tylenol just isn’t enough. The pain associated with injury and surgery is unbearable at times, but many people are understandably cautious about getting prescription narcotics from their doctors because of the obvious habit-forming, addictive risks associated with these medications. Nutra-Pharma Corp. (OTCQB: NPHC) offers a suitable substitute to these potentially dangerous medications with its Nyloxin product – an all-natural product aimed at treating moderate to severe chronic pain. Chronic pain is defined as pain that lasts…

ThursdayJan 21, 2016 12:04 pm

Avant Diagnostics (AVDX): Trials and Tribulations

Recently, in Avant Diagnostics set to exploit new opportunities in the laboratory testing market (http://dtn.fm/hg8TK), we reported that ‘OvaDx is now undergoing 510K trials.’ It seems we jumped the gun. We reached out to Avant’s CEO, Gregg Linn, to get clarification on our report and he confirmed that the OvaDx approval process hasn’t reached the 510K trial stage yet. Avant has been engaged in the calibration testing and validation study phases regarding OvaDx and it expects the 510K trials to commence this year. In September 2015, Avant began calibration testing in preparation for the validation study of OvaDx, which will…

ThursdayJan 21, 2016 10:31 am

Avant Diagnostics, Inc. (AVDX) Ovarian Cancer Early Detection Diagnostic Tech Bolstered Mightily By Amarantus Bioscience Merger

According to recent analysis out late last year from the world’s second largest publisher of premium market reports, MarketsandMarkets, the global market for biomarkers is on-track to grow at a CAGR of 13.58 percent through 2020, reaching upwards of $45.55 billion on the strength of increasing healthcare, as well as R&D spending. A key driver of this growth is the massive importance of biomarkers as an objective means for calculating a pathogenic or pharmacological response to therapeutics, or to gauge the behavior of a normal biological process. Biomarker technology continues to play a pivotal role when it comes to developing…

ThursdayJan 21, 2016 9:53 am

Content Checked Holdings, Inc. (CNCK) Reports Impressive Revenue Growth and Outlines Future Plans in Recent CEO Letter

Talk is cheap, and action - or results to be more accurate - defines whether a company is going in the right direction. There are many innovative ‘idea companies’ out there, but one company making good on its promises and delivering revenue growth, new partnerships, and new products is Content Checked Holdings, Inc. (OTCQB: CNCK). In a recent letter to its shareholders, Content Checked CEO Kris Finstad recapped a rapid, exciting growth history while outlining plans for moving forward. Fundamentals are the baseline measurement for any small-cap startup company to gauge whether or not it is going in the right…

Site Search

Company Search